CCDC141 Mutation Identified in Anosmic Hypogonadotropic Hypogonadism (Kallmann Syndrome) Alters GnRH Neuronal Migration
Author(s) -
B. Ian Hutchins,
Leman Damla Kotan,
Carol TaylorBurds,
Yusuf Özkan,
Paul J. Cheng,
Fatih Gürbüz,
Jean D. R. Tiong,
Eda Mengen,
Bilgin Yüksel,
A. Kemal Topaloğlu,
Susan Wray
Publication year - 2016
Publication title -
endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.674
H-Index - 257
eISSN - 1945-7170
pISSN - 0013-7227
DOI - 10.1210/en.2015-1846
Subject(s) - kallmann syndrome , hypogonadotropic hypogonadism , anosmia , endocrinology , medicine , biology , mutation , gonadotropin releasing hormone , delayed puberty , gene , genetics , hormone , luteinizing hormone , disease , covid-19 , infectious disease (medical specialty)
The first mutation in a gene associated with a neuronal migration disorder was identified in patients with Kallmann Syndrome, characterized by hypogonadotropic hypogonadism and anosmia. This pathophysiological association results from a defect in the development of the GnRH and the olfactory system. A recent genetic screening of Kallmann Syndrome patients revealed a novel mutation in CCDC141. Little is known about CCDC141, which encodes a coiled-coil domain containing protein. Here, we show that Ccdc141 is expressed in GnRH neurons and olfactory fibers and that knockdown of Ccdc141 reduces GnRH neuronal migration. Our findings in human patients and mouse models predict that CCDC141 takes part in embryonic migration of GnRH neurons enabling them to form a hypothalamic neuronal network to initiate pulsatile GnRH secretion and reproductive function.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom